Brief: Shanghai Haohai Biological Technology to make a capital commitment of RMB890 mln in new investment fund
Nov 7 (Reuters) - Shanghai Haohai Biological Technology Co
Ltd 6826.HK
* To make a capital commitment of RMB890 million in
Changxing
Tongrui Investment Partnership Enterprise
Source text for Eikon: urn:newsml:reuters.com:*:nHKS58fY70
Further company coverage: 6826.HK
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Shanghai Haohai Biological Technology
See all newsChina's Haohai Biological H1 revenue falls, partly hurt by end of Brighten Optix distribution
Brief: Shanghai Haohai Biological Technology Says Resignation Of Hou Yongtai As Exec Director, Chair
Brief: Shanghai Haohai Biological Technology Updates On Investigation Of Jiang Wei's Suspected Insider Trading Case
Brief: Shanghai Haohai Biological Technology Proposes To Elect Tian Min As An Additional Executive Director
Brief: Shanghai Haohai Biological Technology Posts Qtrly Net profit Attributable Of RMB73.6 Mln.